Results 121 to 130 of about 87,467 (285)
Background In response to the rapid aging population and increasing number of cancer patients, discussions on dignified end-of-life (EoL) decisions are active around the world.
Il Yun +5 more
doaj +1 more source
ABSTRACT Aim To examine nursing experiences and perspectives regarding conscientious objection in healthcare practice. Design Qualitative Systematic Review. Methods The studies were identified, screened and appraised using the Joanna Briggs Institute (JBI) model and appraisal tools to assess the quality of the data and ensure rigorous evaluation.
Abdulrahman Alghathayan +2 more
wiley +1 more source
ABSTRACT Aims To identify healthcare professionals' experiences of innovation competence and the factors associated with it; and to examine the instruments developed to assess innovation competence and its associated factors among healthcare professionals. Design A mixed‐methods systematic review.
Mari Saukkoriipi +4 more
wiley +1 more source
Moral Distress Among Family Caregivers: A Concept Analysis
ABSTRACT Aim To examine and define the concept of moral distress among family caregivers by identifying its key attributes, antecedents and consequences. Design Concept analysis. Methods This study was guided by Walker and Avant's concept analysis framework.
Tharaa Ananzeh +4 more
wiley +1 more source
ABSTRACT Background Mortal distress encompasses emotional, cognitive, physical and behavioural responses to death and dying among healthcare staff who frequently encounter mortality in hospital settings. Healthcare workers often experience heightened levels of mortal distress due to their regular exposure to patient deaths, which can negatively impact ...
Joy Juan Wang +4 more
wiley +1 more source
Awareness and Misperceptions of Hospice and Palliative Care: A Population-Based Survey Study
Ariel Shalev +5 more
semanticscholar +1 more source
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study
This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin +24 more
wiley +1 more source
Hospice care and nursing care of cancer patients
this article simply outlined the development and structure of service organization of hospice care and nursing care, summarized the keystones of hospice care and nursing care of patients including symptoms control, providing psychological support to ...
朱丽霞, 高凤莉
doaj
Systematic review (51 studies; 547 patients) indicates dupilumab may unmask/worsen CTCL (mainly MF/SS). A French Delphi consensus recommends rigorous diagnostic workup, avoiding dupilumab in confirmed CTCL, discontinuing upon diagnosis, and favouring methotrexate or phototherapy.
Florent Amatore +8 more
wiley +1 more source

